Initial Single-Center Experience With Sirolimus After Lung Transplantation

Transplantation Proceedings

Volumn 38, Issue 9, 2006, Pages 3006-3011

  Lischke, R ^a   Simonek, J ^a   Matousovic, K ^a   Stolz, A J ^a   Schutzner J ^a   Vojacek J ^a   Burkert, J ^a   Davidova R ^a   Pafko, P ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CALCINEURIN INHIBITOR; CREATININE; DACLIZUMAB; GANCICLOVIR; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; RAPAMYCIN; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE; VALGANCICLOVIR;

ADULT; ARTICLE; BACTERIAL INFECTION; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; FEMALE; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; LEUKOPENIA; LUNG FUNCTION TEST; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; UREMIA;

BRONCHIOLITIS OBLITERANS; CREATININE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; SIROLIMUS; SURVIVORS; TACROLIMUS;

EID: 33750952871     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.105     Document Type: Article

References (21)

1. Broekroelofs J., Navis G.J., Stegeman C.A., et al. Long-term renal outcome after lung transplantation is predicted by the 1-month postoperative renal function loss. Transplantation 69 (2000) 1624
2. Broekroelofs J., Stegeman C.A., Navis G.J., et al. Creatinine-based estimation of rate of long term renal function loss in lung transplant recipients. Which method is preferable?. J Heart Lung Transplant 19 (2000) 256
3. Campistol J.M., and Grinyo J.M. Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity. Transplantation 71 11 Suppl (2001) SS42
4. Trulock E.P., Edwards L.B., Taylor D.O., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005. J Heart Lung Transplant 24 (2005) 956
5. Palmer S.M., Baz M.A., Sanders L., et al. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection. Transplantation 71 (2001) 1772
6. Hernandez R.L., Gil P.U., Gallo C.G., et al. Rapamycin in lung transplantation. Transplant Proc 37 (2005) 3999
7. Villanueva J., Boukhamseen A., and Bhorade S.M. Successful use in lung transplantation of an immunosuppressive regimen aimed at reducing target blood levels of sirolimus and tacrolimus. J Heart Lung Transplant 24 (2005) 421
8. Bennett W.M. The nephrotoxicity of new and old immunosuppressive drugs. Ren Fail 20 (1998) 687
9. Groetzner J., Kur F., Spelsberg F., et al. Munich Lung Transplant Group: Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. J Heart Lung Transplant 23 (2004) 632
10. Dutly A.E., Gaspert A., Inci I., et al. The influence of the rapamycin-derivate SDZ RAD on the healing of airway anastomoses. Eur J Cardiothorac Surg 24 (2003) 154
11. King-Biggs M.B., Dunitz J.M., Park S.J., et al. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. Transplantation 75 (2003) 1437
12. Kahan B.D. Sirolimus: a new agent for clinical renal transplantation. Transplant Proc 29 (1997) 48
13. Shitrit D., Rahamimov R., Gidon S., et al. Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: results of a controlled pilot study. Kidney Int 67 (2005) 1471
14. Groetzner J., Meiser B., Landwehr P., et al. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure. Transplantation 77 (2004) 568
15. Groetzner J., Kaczmarek I., Landwehr P., et al. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients. Eur J Cardiothorac Surg 25 (2004) 333
16. Snell G.I., Levvey B.J., Chin W., et al. Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. J Heart Lung Transplant 21 (2002) 540
17. Venuta F., De Giacomo T., Rendina E.A., et al. Recovery of chronic renal impairment with sirolimus after lung transplantation. Ann Thorac Surg 78 (2004) 1940
18. Andoh T.F., Burdmann E.A., Fransechini N., et al. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 50 (1996) 1110
19. Napoli K.L., Wang M.E., Stepkowski S.M., et al. Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions. Ther Drug Monit 20 (1998) 123
20. Cahill B.C., Somerville K.T., Crompton J.A., et al. Early experience with sirolimus in lung transplant recipients with chronic allograft rejection. J Heart Lung Transplant 22 (2003) 169
21. Chueh S.C., and Kahan B.D. Clinical application of sirolimus in renal transplantation: an update. Transpl Int 18 (2005) 261